These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10636750)

  • 1. Spironolactone in patients with heart failure.
    Fernandez HM; Leipzig RM
    N Engl J Med; 2000 Jan; 342(2):132; author reply 133-4. PubMed ID: 10636750
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple therapy can achieve striking reductions in frusemide dosage.
    Jolobe OM
    Cardiology; 2009; 114(4):271; author reply 272. PubMed ID: 19684397
    [No Abstract]   [Full Text] [Related]  

  • 3. [Renal effect of treatment for heart failure].
    Rasmussen ZZ; Barfod T; Klit J
    Ugeskr Laeger; 2009 Feb; 171(9):718. PubMed ID: 19257999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibitors for congestive heart failure.
    Med Lett Drugs Ther; 1988 Oct; 30(777):97-8. PubMed ID: 3173235
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of mild to moderately severe heart insufficiency].
    Kaufmann G
    Schweiz Rundsch Med Prax; 1988 May; 77(19):509-10. PubMed ID: 3387738
    [No Abstract]   [Full Text] [Related]  

  • 6. Spironolactone for congestive heart failure.
    Lindbloom EJ; Koenig CJ
    J Fam Pract; 1999 Oct; 48(10):752. PubMed ID: 12224671
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of chronic heart failure with digitalis: are there still indications?].
    Strasser RH
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S32-6. PubMed ID: 10535044
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-aldosterone therapy in severe heart failure].
    van Guldener C; Donker AJ
    Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1724-6. PubMed ID: 10494316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin and angiotensin converting enzyme inhibitors in chronic heart failure.
    Gheorghiade M
    Can J Cardiol; 1990 Aug; 6 Suppl C():14C-17C. PubMed ID: 2205342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New prospects in diagnosis and treatment of heart failure].
    Pfister U; Lerch R; Hess OM
    Praxis (Bern 1994); 2002 Jan; 91(5):177-80. PubMed ID: 11865776
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An elderly man with known heart failure admitted with cardiogenic shock].
    Hovland A; Fagerheim AK; Hardersen R; Nielsen EW
    Tidsskr Nor Laegeforen; 2010 Jul; 130(13):1352-4. PubMed ID: 20596117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone for heart failure.
    Med Lett Drugs Ther; 1999 Sep; 41(1061):81-2. PubMed ID: 10505071
    [No Abstract]   [Full Text] [Related]  

  • 15. Cross-sectional study of heart failure therapy with angiotensin converting enzyme inhibitors and digoxin.
    Mahmood SA; Hussein GM; Hamza EA
    Saudi Med J; 2004 Aug; 25(8):1060-5. PubMed ID: 15322598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors.
    Joffe I
    N Engl J Med; 1993 Dec; 329(24):1820. PubMed ID: 8232503
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of spironolactone in dogs with chronic heart failure because of degenerative valvular disease: a population-based, longitudinal study.
    Lefebvre HP; Ollivier E; Atkins CE; Combes B; Concordet D; Kaltsatos V; Baduel L
    J Vet Intern Med; 2013; 27(5):1083-91. PubMed ID: 23869534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of concomitant potassium-sparing diuretics in angiotensin-converting enzyme inhibitor therapy in severe congestive heart failure. Xamoterol in Severe Heart Failure Study Group.
    Bergler-Klein J; Sochor H; Pouleur H; Pacher R; Porenta G; Glogar D
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):194-8. PubMed ID: 7526050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The place of new therapies in the treatment of congestive heart failure. The combination of digitalis and diuretics is always in good place].
    André M; Normand J; Bozio A; Sassolas F; Jocteur-Monrozier D
    Pediatrie; 1992; 47(1):23-9. PubMed ID: 1337772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
    Pitt B; Zannad F; Remme WJ; Cody R; Castaigne A; Perez A; Palensky J; Wittes J
    N Engl J Med; 1999 Sep; 341(10):709-17. PubMed ID: 10471456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.